Kisqali 200 MG daily dose UU 21S
Ended Awarded Last action
- Contract number
- SPE2DR26FT5BQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,560
Award facts
- Contract value 100% obligated
- $30,560.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,560.20 firm fixed price delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Kisqali 200 mg daily dose medication in 21-unit packages. The contract is non-set-aside and competitively awarded, with performance to be completed by January 6, 2026, and fulfillment at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The company's extensive portfolio of federal contract awards with the Defense Logistics Agency demonstrates its capability to fulfill diverse pharmaceutical supply requirements on a competitive basis, ranging from small-value transactions to substantial orders exceeding $45,000, with firm fixed pricing across delivery orders for branded and generic medications, vaccines, and specialized medical supplies supporting multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FT5BQ?
SPE2DR26FT5BQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FT5BQ worth?
The government has obligated $30,560 on SPE2DR26FT5BQ.
Is contract SPE2DR26FT5BQ an order under another contract?
Yes. SPE2DR26FT5BQ is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT5BQ competed?
The extent of competition for SPE2DR26FT5BQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award